Literature DB >> 10696979

Effect of recent thymic emigrants on progression of HIV-1 disease.

A Hatzakis1, G Touloumi, R Karanicolas, A Karafoulidou, T Mandalaki, C Anastassopoulou, L Zhang, J J Goedert, D D Ho, L G Kostrikis.   

Abstract

BACKGROUND: The concentration of T-cell receptor-rearrangement excision DNA circles (TREC) in peripheral-blood T cells is a marker of recent thymic emigrant alphabeta T cells. We studied the predictive ability of measurements of TREC for clinical outcome in HIV-1-infected individuals.
METHODS: We measured TREC in peripheral-blood mononuclear cells with a real-time PCR assay. We studied 131 Greek participants in the Multicenter Hemophilia Cohort Study who had known HIV-1 seroconversion dates. The prognostic value of baseline TREC, CD4 T-cell count, and HIV-1 RNA concentration was assessed by Kaplan-Meier and Cox's regression analysis.
FINDINGS: Four participants had progressed to AIDS by first blood sampling. Among the remaining 127 individuals, the median value of TREC per 10(6) cells was 6900 (IQR 2370-15604). Baseline TREC values were lower in the 53 who progressed to AIDS than in those who did not (geometric mean 2843 [95% CI 1468-5504] vs 6560 [4723-9113] per 10(6) cells; p=0.017). The relative hazard of AIDS, adjusted for plasma viral load, CD4 T-cell count, and age at seroconversion was 1.44 (95% CI 1.04-2.01; p=0.031) per ten-fold increase in TREC; that for death was 1.52 (1.12-2.06; p=0.007). The adjusted relative hazards of death were 2.91 (1.91-4.44; p<0.001) per ten-fold increase in plasma HIV-1 RNA load and 1.20 (1.04-1.38; p=0.014) per 100-cell decrease in CD4 T-cell count.
INTERPRETATION: The concentration of TREC in the peripheral T-cell pool complements HIV-1 RNA load and CD4 T-cell count in predicting the rate of HIV-1 disease progression. Recent thymic emigrants have a role in the pathogenesis of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696979     DOI: 10.1016/S0140-6736(99)10311-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Immune Reconstitution Strategies in HIV.

Authors:  Matthew R. Leibowitz; Ronald T. Mitsuyasu
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

3.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 4.  Thymic function in HIV infection.

Authors:  Rohan Hazra; Crystal Mackall
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

5.  Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

Authors:  Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

6.  Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression.

Authors:  Sara Ferrando-Martinez; Rebeca S De Pablo-Bernal; Marta De Luna-Romero; Santiago J De Ory; Miguel Genebat; Yolanda M Pacheco; Francisco J Parras; Marta Montero; Jose Ramón Blanco; Felix Gutierrez; Jesus Santos; Francisco Vidal; Richard A Koup; María Ángeles Muñoz-Fernández; Manuel Leal; Ezequiel Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

7.  Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Authors:  Leondios G Kostrikis; Giota Touloumi; Rose Karanicolas; Nikos Pantazis; Cleo Anastassopoulou; Anastasia Karafoulidou; James J Goedert; Angelos Hatzakis
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  The contribution of the thymus to the recovery of peripheral naive T-cell numbers during antiretroviral treatment for HIV infection.

Authors:  Ruy M Ribeiro; Rob J de Boer
Journal:  J Acquir Immune Defic Syndr       Date:  2008-09-01       Impact factor: 3.731

9.  Cellular calibrators to quantitate T-cell receptor excision circles (TRECs) in clinical samples.

Authors:  Divya Punwani; Diana Gonzalez-Espinosa; Anne Marie Comeau; Amalia Dutra; Evgenia Pak; Jennifer Puck
Journal:  Mol Genet Metab       Date:  2012-09-21       Impact factor: 4.797

10.  Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe.

Authors:  Victoria L Demetriou; David A M C van de Vijver; Ioanna Kousiappa; Claudia Balotta; Bonaventura Clotet; Zehava Grossman; Louise B Jørgensen; Snjezana Z Lepej; Itzchak Levy; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Francois Roman; Lidia Ruiz; Jean-Claude Schmidt; Anne-Mieke Vandamme; Kristel Van Laethem; Jurgen Vercauteren; Leondios G Kostrikis
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.